Ustekinumab in the Treatment of Severe Atopic Dermatitis: A Preliminary Report of Our Experience With 4 Patients
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
4 Patients ଝ Ustekinumab en el tratamiento de la dermatitis atópica severa.Nuestra experiencia en 4 pacientes.Informe preliminarTable 1 Summary of the Epidemiological, Clinical, and Therapeutic Characteristics of our Patients.Patient 1 Patient 2 Patient 3 Patient 4 Age 28 29 29 23 Onset of AD Childhood Childhood Childhood Childhood Hay fever Yes Yes Yes Yes Asthma No Yes Yes No Sex Male Male Male
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New insights into atopic dermatitis
Leung, D. Y. M., Boguniewicz, M., Howell, M. D., Nomura, I., & Hamid, Q. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21060 · Cited by 1,435
Research works printed but not linked: 5
- Puya, 2012, Treatment of severe refractory adult atopic dermatitis with ustekinumab, Int J Dermatol, 51, 115, 10.1111/j.1365-4632.2011.05195.x · DOI · Paper page
- Koutruba, 2010, Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis, Ther Clin Risk Manag, 6, 123
- Kikly, 2006, The IL-23/Th17 axis: Therapeutic targets for autoimmune inflammation, Curr Opin Immunol, 18, 670, 10.1016/j.coi.2006.09.008 · DOI · Paper page
- Steward-Tharp, 2010, New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression, Ann N Y Acad Sci., 1183, 123, 10.1111/j.1749-6632.2009.05124.x · DOI
- Coondoo, 2009, Biologics in dermatology therapy, an update, Indian J Dermatol, 54, 211, 10.4103/0019-5154.55627 · doi:10.4103/0019-5154.55627
Cited by
Noda, S., Suárez-Fariñas, M., Ungar, B., Kim, S. J., de Guzman Strong, C., Xu, H., Peng, X., Estrada, Y. D., Nakajima, S., Honda, T., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.015 · Cited by 657
The Role of Th17-Related Cytokines in Atopic Dermatitis
Sugaya, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041314 · Cited by 204
“A previous report about four male patients with severe AD between 23 and 29 years old, whose skin eruption had been refractory to oral corticosteroids, phototherapy, and to at least two systemic drugs, showed improvement of SCORAD and itch score after treatment with 45 mg of ustekinumab injection at 0, 4 weeks, and ev…”
BackgroundNovel Biologicals for the Treatment of Allergic Diseases and Asthma
Tan, H.-T. T., Sugita, K., & Akdis, C. A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0650-5 · Cited by 68
Metadata
- Authors
- Fernández-Antón Martínez, M. C., Alfageme Roldán, F., Ciudad Blanco, C., & Suárez Fernández, R.
- Venue
- Actas Dermo-Sifiliográficas (English Edition)
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 105
- Issue
- 3
- Pages
- 312-313
- ISSN
- 0001-7310 (ISSN-L)
- 1578-2190
- OpenAlex
- W1964391451
- Cited by
- 39
- References
- 1
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 2347 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.